The ADA (American Diabetic Association) and NICE (National Institute for Clinical Evidence) in the United Kingdom have established evidence based guidelines for the initiation and maintenance of oral antidiabetic and insulin therapy in patients with type 2 diabetes. We hypothesis that not all patients with type 2 diabetes at the University of Kentucky Health Maintenance Organization (UK-HMO) are initiated on oral antidiabetic medication according to guidelines and that many combinations of medication are used. To describe trends and combinations of prescription antidiabetic drugs and insulin usage among patients with type 2 diabetic at the UK-HMO. A retrospective medication utilization evaluation of prescription records at the UK-HMO identi...
Aims. The aim of this study was to investigate the impact of new insights and revised guidelines on ...
textabstractObjective To explore the 'real-life' therapy of type 2 diabetes mellitus with oral antid...
Background: T2DM patients can be treated with both Insulin or/and non-insulin antidiabetic drugs. Bi...
The ADA (American Diabetic Association) and NICE (National Institute for Clinical Evidence) in the U...
OBJECTIVE — The mid-1990s witnessed the introduction of new classes of medications to treat hypergly...
Victoria Higgins, James Piercy, Adam Roughley, Gary Milligan, Andrea Leith, ...
BACKGROUND: Many patients with type 2 diabetes eventually require insulin, yet little is known about...
OBJECTIVE — To describe the use of oral antidiabetic drugs for management of type 2 diabetes in the ...
OBJECTIVE: To evaluate antidiabetic drug treatment patterns and glycemic control among patients diag...
To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patterns, alon...
Introduction Prescription patterns of antidiabetic drugs in the period from 2012 to 2018 were invest...
Abstract Background Type 2 diabetes is an important cause of morbidity and mortality. Its prevalence...
OJBECTIVE To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patt...
Introduction: Assessing anti-diabetic drug use patterns in hospitals is an important activity which ...
Aims UK guidelines for type II diabetes leave the choice of glucose lowering therapies after metform...
Aims. The aim of this study was to investigate the impact of new insights and revised guidelines on ...
textabstractObjective To explore the 'real-life' therapy of type 2 diabetes mellitus with oral antid...
Background: T2DM patients can be treated with both Insulin or/and non-insulin antidiabetic drugs. Bi...
The ADA (American Diabetic Association) and NICE (National Institute for Clinical Evidence) in the U...
OBJECTIVE — The mid-1990s witnessed the introduction of new classes of medications to treat hypergly...
Victoria Higgins, James Piercy, Adam Roughley, Gary Milligan, Andrea Leith, ...
BACKGROUND: Many patients with type 2 diabetes eventually require insulin, yet little is known about...
OBJECTIVE — To describe the use of oral antidiabetic drugs for management of type 2 diabetes in the ...
OBJECTIVE: To evaluate antidiabetic drug treatment patterns and glycemic control among patients diag...
To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patterns, alon...
Introduction Prescription patterns of antidiabetic drugs in the period from 2012 to 2018 were invest...
Abstract Background Type 2 diabetes is an important cause of morbidity and mortality. Its prevalence...
OJBECTIVE To explore temporal trends in antidiabetes drug (ADD) prescribing and intensification patt...
Introduction: Assessing anti-diabetic drug use patterns in hospitals is an important activity which ...
Aims UK guidelines for type II diabetes leave the choice of glucose lowering therapies after metform...
Aims. The aim of this study was to investigate the impact of new insights and revised guidelines on ...
textabstractObjective To explore the 'real-life' therapy of type 2 diabetes mellitus with oral antid...
Background: T2DM patients can be treated with both Insulin or/and non-insulin antidiabetic drugs. Bi...